Back to Search Start Over

Synaffix enters into Hummingbird Bioscience licensing agreement

Source :
M2 Pharma. January 5, 2023
Publication Year :
2023

Abstract

M2 PHARMA-January 5, 2023-Synaffix enters into Hummingbird Bioscience licensing agreement (C)2023 M2 COMMUNICATIONS Synaffix BV, a Dutch biotechnology company, announced on Wednesday that it has entered into a licensing agreement [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Pharma
Publication Type :
News
Accession number :
edsgcl.732248933